Atwater Malick’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $528K | Buy |
2,846
+135
| +5% | +$25.1K | 0.17% | 54 |
|
|
2025
Q1 | $568K | Sell |
2,711
-13
| -0.5% | -$2.72K | 0.19% | 50 |
|
|
2024
Q4 | $484K | Hold |
2,724
| – | – | 0.16% | 49 |
|
|
2024
Q3 | $538K | Sell |
2,724
-40
| -1% | -$7.9K | 0.17% | 51 |
|
|
2024
Q2 | $474K | Hold |
2,764
| – | – | 0.16% | 53 |
|
|
2024
Q1 | $503K | Buy |
2,764
+1,095
| +66% | +$199K | 0.18% | 56 |
|
|
2023
Q4 | $259K | Sell |
1,669
-468
| -22% | -$72.5K | 0.1% | 62 |
|
|
2023
Q3 | $319K | Hold |
2,137
| – | – | 0.14% | 55 |
|
|
2023
Q2 | $288K | Buy |
2,137
+510
| +31% | +$68.7K | 0.12% | 59 |
|
|
2023
Q1 | $259K | Buy |
1,627
+24
| +1% | +$3.83K | 0.12% | 55 |
|
|
2022
Q4 | $259K | Buy |
+1,603
| New | +$259K | 0.13% | 51 |
|
|
2019
Q4 | – | Sell |
-686
| Closed | -$52K | – | 39 |
|
|
2019
Q3 | $52K | Buy |
+686
| New | +$52K | 0.04% | 74 |
|